Progesterone Pre-treatment Potentiates EGF Pathway Signaling in The Breast Cancer Cell Line ZR-75*

Author： Carvajal A.  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.94, Iss.2, 2005-11, pp. : 171-183

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CDK5RAP1 deficiency induces cell cycle arrest and apoptosis in human breast cancer cell line by the ROS/JNK signaling pathway

By  

Oncology Reports, Vol. 33, Iss. 3, 2015-01 ,pp. : 1089-1096

Spandidos Publications

Access to resources Recommend Favorite

LHX6 inhibits breast cancer cell proliferation and invasion via repression of the Wnt/βcatenin signaling pathway

By    

Molecular Medicine Reports, Vol. 12, Iss. 3, 2015-01 ,pp. : 4634-4639

Spandidos Publications

Access to resources Recommend Favorite

Onapristone, a Progesterone Receptor Antagonist, as First-line Therapy in Primary Breast Cancer

By Robertson J.F.R.   Willsher P.C.   Winterbottom L.   Blamey R.W.   Thorpe S.  

European Journal of Cancer, Vol. 35, Iss. 2, 1999-02 ,pp. : 214-218

Elsevier

Access to resources Recommend Favorite

Regulation of the cell cycle and PI3K/Akt/mTOR signaling pathway by tanshinone I in human breast cancer cell lines

By  

Molecular Medicine Reports, Vol. 11, Iss. 2, 2015-01 ,pp. : 931-939

Spandidos Publications

Access to resources Recommend Favorite

The Value of Pre-operative Lymphoscintigraphy in Breast Cancer Treatment

By Uren R.F.   Howman-Giles R.B.   Thompson J.F.  

European Journal of Cancer, Vol. 34, Iss. 1, 1998-01 ,pp. : 203-204

Elsevier

Access to resources Recommend Favorite